It has been proposed that the first detectable pathological tau variant in the CSF and plasma of patients with AD is p-Tau181, followed sequentially by p-Tau217, p-Tau231, pT205, MTBR-Tau243, and eventually non-phosphorylated tau fragments [14]. The gene discussed is MAPT; the disease is Alzheimer disease.